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deterioration (END) of isolated acute lacunar infarction.
Methods: 167 patients, in the retrospective group, with isolated acute lacunar infarction
in basal ganglia, were defined by magnetic resonance imaging (MRI). The National
Institutes of Health Stroke Scale (NIHSS) defined early neurological deterioration as
increases of ≥ 2 within 72 hours following admission. Baseline variables predicting
END were investigated with multivariate logistic regression analysis.
Results: In the study, END occurred in 42 (25.15%) patients. Lesions located in posterior
limb of internal capsule were independent risk factors for END (P < 0.01). Associated
with END were the age of onset, history of cerebral infarction, history of diabetes, systolic
blood pressure at admission and lesions of cerebral white matter. This presented
significant differences (P < 0.05). With or without diabetes and different lesion location
at varying layers and inter-layers, single-factor and multi-factor analysis revealed no
effect on the association between positive ENT and age, history of stroke, white matter.
Previous history of stroke, pathological changes of white matter, and age of onset,
correlates with END which showed significant difference (P < 0.05).
Conclusions: There is a close relationship between the lesion location and other
related factors, such as lesions of cerebral white matter, history of cerebral infarction,
history of diabetes and age, etc. and END in patients with isolated acute lacunar
infarction in basal ganglia. Protective factors of END included age ≥ 65, high systolic
pressure, stroke history, cerebral white matter lesions in our study.

1

Introduction

In 20%~30% of patients with unilateral isolated basal
ganglia lacunar infarction, early neurological deterioration (END) occurs. It leads to one of the main causes
for poor prognosis, post stroke, and END may progress
to severe disability within several hours or days [1, 2].
The basal ganglia region is vascularized by anterior
choroidal artery (AChA), internal capsule-striatum
artery, and thalamo-geniculate artery. The majority of
studies showed that perforating branches atherosclerosis
or hypoperfusion results in END. In this study, we

focused on other possible factors that cause deterioration
of neurological function and probed into the mechanisms
by excluding patients with internal carotid artery and
the ipsilateral middle cerebral artery stenosis.

2

Methods

2.1

Patients

In this study, the data of 167 patients suffering from
unilateral isolated basal ganglia lacunar cerebral
infarction, between July 2012 and June 2015, were
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retrospectively reviewed at the Department of Neurology at the Affiliated Weihai Center Hospital. Within
24 h after admission, magnetic resonance imaging
(MRI), diffusion weighted imaging (DWI) and magnetic resonance angiography (MRA) confirmed their
diagnoses. MRI, MRA and neck and/or intracranial
vascular examination were performed, according to
the standard of Chinese Acute Ischemic Stroke Treatment
Guidelines (2010 version). Exclusion in this study were
those patients with lesions extended to the body of
the lateral ventricle, cortex, and centrum semiovale.
Based on the trial of ORG 10172 in acute stroke
treatment (TOAST) classification [3], those patients
with internal carotid artery and the ipsilateral middle
cerebral artery stenosis, were also excluded. Through
the application and indication of DWI, patients with
acute multi-lacunar infarction, bilateral cortex and
subcortex acunar infarction were excluded. In addition,
patients who were also excluded with lateral ventriculitis, tumor, demyelinating diseases, neural function
loss caused by previous stroke history and acute
cerebral infarction outside the paraventricular region.
According to the National Institutes of Health Stroke
Scale (NIHSS) score, END-positive patients were defined
as who with increased NIHSS score ≥ 2 within
72 h after admission. Composed of 42 patients was
the END-positive group, while the other 125 patients
made up the END-negative group.
2.2

Method

2.2.1 General information
Detailed records of patients were collected, including
age, gender, previous medical history (including
high blood pressure, diabetes, stroke history), and
individual history (smoking and drinking history). As
well, the period from onset time to admission time,
duration until peak, main laboratory index (admission
blood glucose concentration, hemoglobin A1c reading,
total cholesterol, triglyceride levels, low-density
lipoproteins, coagulation function, C-reactive protein,
uric acid, homocysteine), 12-lead electrocardiogram
(ECG), echocardiogram, cervical vascular color
ultrasonic and transcranial Doppler (TCD) exam were
also collected.
2.2.2 Image examination
Those patients having given informed consent were

examined using 1.5 T (Signa 1.5 T, General Electric,
USA) or 3.0 T (MAGENTOM 3.0 T, Siemens, Germany)
MRI system. The MRI examination included T1weighted imaging, T2-weighted imaging, diffusionweighted imaging, fluid-attenuated inversion recovery
pulse sequence and MRA. The infarctions were divided
into ventral, medial or dorsal types based on axial scans
including three front-to-back periventricular anatomic
planes that, in turn, were based on major sites of
infarction in scans of the periventricular body. Whether
the infarction has extended to the radial posterior lateral
ventricle was investigated using T2-weighted imaging
(or DWI). Intracranial vascular examinations were
completed by MRI, or head and neck CT angiography.
2.2.3

Clinical assessments

Initial stroke severity was measured using the NIHSS
on admission. The NIHSS assessments were carried
out on day 3, 7 and 14 after admission and conducted
twice a day (in the morning and the afternoon) by the
same doctor. The highest score on each day was
then recorded. An increase of NIHSS score ≥ 2 within
1 week [4] was defined as END. The doctor who
measured the NIHSS score in this single-blind test
had no knowledge of the imaging findings of the
patients.
2.3

Statistical analysis

Statistical Package for Social Sciences software (SPSS
16.0; IBM, Armonk, New York) was used to analyze
the data. Quantitative data in non-normal distribution
were indicated with medians and quartiles, while
quantitative data in normal distribution were expressed
as x  s . Independent sample t-test was employed
for comparison between the two groups. The two
groups were compared using the c2-test and Fisher’s
exact test, and ranked data were expressed as percentages. Variables with P < 0.1 were exclusively included
in the logistic model to analyze the effects of ENDpredicting factors and adjusted confounders, as
determined in univariate analyses. Differences in age,
gender and lesion location (posterior limb of internal
capsule, posterior part of periventricle and corona
radiata area) were analyzed separately in patient
subgroups. Statistically significant was defined as
P < 0.05.
Journal of Neurorestoratology
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Results

Among the 167 patients with cerebral infarction, 42
showed early neurological deterioration (END-positive),
while 125 did not (END-negative). Patients with high
incidence (P < 0.05) (Table 1) of END were under
the age of 65, whose dorsal parts of periventricle
area were involved, and had lower systolic blood
pressure, higher C-reactive protein and admission
blood glucose level, but had no history of stroke and
leukoencephalopathy.
Stepwise logistic regression to analyze the possible
related factors in END-positive patients (αE = 0.05, αR =
0.10) was performed. Results indicated protective
factors of END (OR value: 0.831, 0.569, 0.797, 0.963,

respectively, P < 0.05) occurred for those patients over
65 years old, who had higher systolic blood pressure,
history of stroke, and leukoencephalopathy. On admission, dorsal infarction and higher level of blood glucose
were independent risk factors for END (OR value are
4.687 and 1.531, respectively, P < 0.05) (Table 2).
We analyzed related univariate and multivariate to
END by hierarchical regression based on the presence
of diabetes and different positions of lacuna infarctions,
because diabetes history and the varying positions of
lacunar infarctions could be the confounding factors
of age, stroke history and white matter lesions. Results
indicated that diabetes mellitus and different positions
of lacunar infarctions did not affect the positive
correlation between END-positive and age, history of

Table 1 General information of END positive and negative patients.
Variable

END negative

END positive

t/χ2 value

P value

Age

< 65
≥ 65

45 (66.18%)
80 (80.81%)

23 (33.82%)
19 (19.19%)

4.584

0.032

Gender

Male
Female

67 (72.83%)
58 (77.33%)

25 (27.17%)
17 (22.67%)

0.446

0.504

NIHSS score at admission

－

1.96 ± 0.57

2.08 ± 0.45

1.245

0.217

Site of infarction

Ventral
Medial
Dorsal

28 (82.35%)
43 (83.31%)
54 (65.85%)

6 (17.65%)
8 (15.69%)
28 (34.15%)

6.969

0.031

Systolic blood pressure (mmHg)

－

149.32 ± 15.41

143.68 ± 14.89

‒2.078

0.040

Diastolic blood pressure (mmHg)

－

83.97 ± 11.12

85.49 ± 9.97

0.792

0.433

Hypertension

No
Yes

34 (79.07%)
91 (73.39%)

9 (20.93%)
33 (26.61%)

0.548

0.459

Diabetes mellitus (DM)

No
Yes

90 (73.77%)
35 (77.78%)

32 (26.23%)
10 (22.22%)

0.280

0.596

Ever smoker

No
Yes

77 (74.76%)
38 (70.37%)

26 (25.24%)
16 (29.63%)

0.348

0.555

Alcohol drinking

No
Yes

54 (76.06%)
71 (73.96%)

17 (23.94%)
25 (26.04%)

0.095

0.757

History of stroke

No
Yes

76 (69.09%)
49 (85.96%)

34 (30.91%)
8 (14.04%)

5.679

0.017

Homocysteine (μmol/L)

－

9.12 ± 2.89

9.67 ± 2.56

1.097

0.274

High density lipoprotein
cholesterol (mmol/L)

－

1.18 ± 0.20

1.22 ± 0.17

1.172

0.246

Low-density lipoproteins (mmol/L)

－

2.68 ± 0.74

2.57 ± 0.82

‒0.815

0.419

Serum creatinine (mmol/L)

－

72.69 ± 20.86

73.83 ± 19.71

0.318

0.757

Serum uric acid (mmol/L)

－

319.15 ± 78.23

311.70 ± 86.26

‒0.527

0.604

C-reactive protein (mmol/L)

－

0.98 ± 0.18

1.13 ± 0.21

4.482

< 0.001

Admission blood glucose (mmol/L)

－

6.35 ± 2.17

7.34 ± 2.26

2.534

0.012

Leukoencephalopathy

No
Yes

72 (67.92%)
53 (86.89%)

34 (32.08%)
8 (13.11%)

7.394

0.007
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Table 2 Multivariate logistic regression analyses of significant risk factors for END.
Variable

β

SE

Wald

P value

OR value

95% CI

Age

‒0.672

0.255

8.637

0.026

0.831

0.422~0.950

Site of infarction
Medialb
Dorsalb

－
0.6334
2.598

－
0.439
0.826

9.085
5.532
12.089

0.006
0.172
0.001

－
1.224
4.687

－
0.834~1.926
2.185~12.239

Systolic blood pressure

–0.286

0.097

6.903

0.042

0.569

0.334~0.8892

History of stroke

–1.235

0.338

8.531

0.026

0.797

0.598~0.964

C-reactive protein

0.582

0.115

4.064

0.285

1.003

0.851~1.461

Admission blood glucose

0.339

0.082

8.012

0.024

1.531

1.143~1.982

Leukoencephalopathy

–1.539

0.673

10.137

0.003

0.963

0.885~0.997

a

c

a, age<65 as reference criterion; b, ventral infarction as reference criterion; c, without leukoencephalopathy as reference criterion.

stroke or leukoencephalopathy (Table 3).

4

Discussions

A common ischemic stroke in deep brain regions
featured by high END incidence rate and disability
rate is basal ganglia lacunar stroke. Further neurofunctional injury can occur rapidly and peak in
3~5 days even though it begins with a mild nerve
function deficit. The curative effect and prognosis
were limited by the narrow thrombolysis treatment
time-windows. The fact that perforating arterial
Table 3

The correlation between END positive and age, stroke history or leukoencephalopathy.

Variable
DM

SI

occlusions play a crucial role in basal ganglia lacunar
stroke is currently widely accepted. Nevertheless,
radiological examinations rarely found lesions at the
perforating artery; even digital subtraction angiography
(DSA) exams are unable to identify carotid artery
stenosis or perforating artery occlusion [1]. Low perfusion watershed infarction, as suggested by other
studies, could contribute its pathogenesis. In addition,
lenticulostriate artery lesion, middle cerebral artery
stenosis or Heubner recurrent artery stenosis may be
involved [5, 6]. Basal ganglia lacunar stroke related
risk factors, based on the administered patients from

Age

Stroke history

Leukoencephalopathy

≥65

<65

With

Without

With

Without

0.892
(0.334~0.926)

1.384
(1.029~2.671)

0.764
(0.589~0.897)

1.183
(1.002~1.639)

0.808
(0.773~0.934)

1.205
(1.137~1.689)

YESb

0.711
(0.389~0.871)

1.038
(1.071~2.394)

0.708
(0.435~0.826)

1.267
(1.317~1.925)

0.724
(0.539~0.894)

1.178
(1.089~2.006)

Ventralc

0.734
(0.689~1.832)

1.591
(1.257~2.039)

0.938
(0.572~0.985)

1.083
(1.061~2.192)

0.831
(0.702~0.929)

1.282
(1.029~1.591)

Mediald

0.972
(0.681~0.994)

1.432
(1.115~2.447)

0.793
(0.618~0.906)

1.256
(1.097~2.058)

0.794
(0.605~0.883)

1.539
(1.373~1.992)

Dorsale

0.989
(0.683~0.998)

2.385
(1.639~4.159)

0.893
(0.694~0.949)

3.281
(1.773~5.201)

0.835
(0.772~0.972)

2.338
(1.524~4.384)

NO

a

DM: diabetes mellitus; SI: site of infarction.
In each regression model, the adjusted independent variables were composed of variables which were statistically significant (P < 0.1) in the
stratified univariate analysis. a, adjusted for NIHSS score at admission, SI, C-reactive protein and admission blood glucose concentration;
b, adjusted for NIHSS score at admission, SI, systolic blood pressure, ever smoker, low-density lipoproteins concentration, C-reactive
protein and admission blood glucose concentration; c, adjusted for NIHSS score at admission, systolic blood pressure, hypertension, DM,
high-density lipoprotein cholesterol concentration, low-density lipoproteins and C-reactive protein concentration; d, adjusted for gender,
NIHSS score at admission, systolic blood pressure, hypertension, DM, high-density lipoprotein cholesterol concentration, C-reactive
protein and admission blood glucose concentration; e, adjusted for NIHSS score at admission, systolic blood pressure, DM, C-reactive
protein and admission blood glucose concentration.
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the past two years, were analyzed in this retrospective
study. We assessed NIHSS score to identify END
positive patients after excluding large-artery atherosclerosis diagnosis. An END incident rate around
10% ~ 40% was found in previous studies [7]. Our END
data showed the incident rate is 25.15%, which is
consistent with the previous reports. The incidence
of our study generated a lower percentage than in
previous studies because the large-artery atherosclerosis
patients were excluded, which reduced the study
sample size.
Moreover, we also found a significant correlation
between END and lesion location, age, white matter
lesions, history of stroke or diabetes, and systolic blood
pressure on hospital admission. In addition, posterior
lateral ventricle lesions are significantly correlated to
END (P < 0.01). The history of diabetes and systolic
blood pressure on admission is associated with END
as well (P < 0.05), which is consistent with the previous
studies [8]. Contrary to previous studies, which
reported no correlation between white matter lesions
classification and lacunar cerebral infarction induced
END [9], our research suggested that the protective
factors in lacunar stroke include history of stroke,
white matter lesions and age. A brain ischemia
tolerance after lacunar stroke may be activated by
the protective factors.
The body’s ability to tolerate against cerebral
ischemia events is called brain ischemia tolerance.
Related protection mechanisms can be activated and
protect ensuing ischemic injury, which reduce lesion
volume, and alleviate neural function impairment
after cerebral blood reperfusion. Included in these
mechanisms are two endogenous protective strategies:
ischemic preconditioning (IP) and ischemic postconditioning (IPC). IP, an earlier proposed neural protective strategy that occurs after subconscious stimulus
and before harmful ischemia, can be divided into
two stages: the rapid pretreatment (3 ~ 5 min after
the preconditioning stimulus, after 1 h), and delayed
preconditioning (start after 2~3 d pretreatment, after
1 week). Extremely complicated, neural protective
mechanisms in IP are involved with many gene
expressional regulations and signal transduction
pathways. IPC is the other endogenous protective
strategy, which is recently discovered, induces ischemia
tolerance in target organs to reduce ischemia-
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reperfusion injury and protect normal function.
To date, it is not fully clear what the mechanism is
for novel neural protection strategy to induce brain
ischemia tolerance. The transient whole-brain or
partial-brain region ischemia, as being revealed
through a number of pre-clinical experiments, showed
neural-protective functions in severe ischemia even
following a specific time interval to ischemia stimulation
[10, 11]. Patients with history of transient ischemic
attack (TIA) equivalent are also experiencing IP, which
may belong to IPC. Clinical study indicated that TIA
would affect re-ischemia by two main approaches:
cumulative damage and protective tolerance. As well,
other studies have also demonstrated that if two
ischemia episodes occur continuously in a few hours,
the second ischemia episode would aggravate the
first one; this is known as cumulative damage. IP is
observed to be activated and protect against lethal
re-ischemia, if the time interval between two ischemia
episodes is extended [12]. Indeed, patients with longer
interval between TIA and infarction, as observed
by Caplan et al. [13], were proved to have a better
prognosis vs. patients without prior TIA or with short
interval. This finding suggested an ischemic tolerance
effect in neural protection function.
Partially similar to natural adaptation mechanisms
were the characteristics of brain ischemia tolerance.
The history of cerebral infarction in patients and
cerebral white matter lesions was investigated in this
study. A small vascular lesion induced by chronic
ischemia might be suggested by cerebral white matter
lesions. An endogenous protective mechanism for
protective tolerance may be activated by these factors.
A high incidence of chronic hypoperfusion, which is
a feature of leukoencephalopathy, in small vascular
lesions was exhibited on hypertension patients. The
low microcirculatory perfusion status before infarction
possibly activates IP and leads to gene expression
regulation and cell defense mechanism strengthening
against acute ischemia. This might play a significant
role in early neurologic protection and prevent disease
progression from worsening [14, 15]. In addition,
having less capacity to tolerate stroke attack, younger
patients present a more severe impairment compared
to elderly patients. Still, other neural regulation
mechanisms may be involved for later neural function
rehabilitation. Therefore, significant indicators for early
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neurologic deterioration may include age, history of
cerebral infarction, and cerebral white matter lesions.
Protective factors of END included age ≥ 65, high
systolic pressure, stroke history, cerebral white matter
lesions in our study. In basal ganglia lacunar stroke
patients, ischemia intolerance is the main mechanism
of END. Perhaps more importantly, repeated IP and
ICP may be induced by prior cerebral infarction or
cerebral white matter lesions. This, in turn, could
activate endogenous protective mechanisms, thereby
promotes the establishment of collateral circulation
and enhances the ability to fight against subsequent
ischemic events at last. Currently, many IP methods
such as hyperbaric oxygen and electric acupuncture,
which enhance cerebral ischemia tolerance have been
employed [16, 17]. Although these approaches are
proved to be effective in animal experiments, the
mechanism of formation of cerebral ischemia tolerance
is not completely understood yet. It is possible that
heat shock protein 70 (HSP70) in mitochondria, brainderived erythropoietin, cell signaling pathways, TNF-α,
Bcl-2 or neurotransmitters may be involved in formation
of cerebral ischemia tolerance [10, 18-21]. The continuous development of molecular biology and genetic
techniques makes it more possible to identify cerebral
ischemia tolerance involving gene location and function. This then would provide new theoretical bases
for new brain protective drug discovery, and open
up new avenues to reveal new targets for ischemic
cerebrovascular disease prevention and treatment. The
inadequacy of this report is that the representation of
patients may not be sufficient, since the sample size
is small. Finally, long-term function and prognosis of
patients with unilateral isolated basal ganglia lacunar
infarction still need to be further confirmed.
In conclusions, there is a close relationship between
the lesion location and other related factors such as
lesions of cerebral white matter, history of cerebral
infarction, history of diabetes and age, etc. and END
in patients with isolated acute lacunar infarction in
basal ganglia. Protective factors of END included age
≥ 65, high systolic pressure, stroke history, cerebral
white matter lesions in our study.
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